Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-12-30 00:00:00 ET · period of report 2022-12-28 · accession 0001209191-22-062992 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-30 | 2022-12-28 | PCVX | Dhaliwal Harpreet S. | SVP Cml Mfg, Supply Chain | M - OptEx | $25.06 | +3,990 | 21.8K | +22% | +$100.0K |
| D | 2022-12-30 | 2022-12-28 | PCVX | Dhaliwal Harpreet S. | SVP Cml Mfg, Supply Chain | D - Sale to Iss | $0.00 | +3,990 | 96.0K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-28 | M | A | 3,990 | $25.06 | 21,808 | D | — | — | (F1) Includes 928 shares acquired under the Vaxcyte, Inc. Employee Stock Purchase Plan on November 17, 2022. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-12-28 | D | A | 3,990 | $0.00 | 96,010 | D | $25.06 · — to 2031-11-07 | 3,990 Common Stock | (F2) 1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |